Does etanercept monotherapy enhance the risk of Listeria monocytogenes meningitis?

被引:17
作者
Pagliano, P [1 ]
Attanasio, V [1 ]
Fusco, U [1 ]
Mohamed, DA [1 ]
Rossi, M [1 ]
Faella, FS [1 ]
机构
[1] D Cotugno Hosp, Dept Emergency, Div Infect Neuropathies, I-80131 Naples, Italy
关键词
D O I
10.1136/ard.2003.015966
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:462 / 463
页数:2
相关论文
共 10 条
[1]   Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study [J].
Doran, MF ;
Crowson, CS ;
Pond, GR ;
O'Fallon, WM ;
Gabriel, SE .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2287-2293
[2]   Anti-TNFα therapy is useful in rheumatoid arthritis and Crohn's disease:: Analysis of the mechanism of action predicts utility in other diseases [J].
Feldman, M ;
Taylor, P ;
Paleolog, E ;
Brennan, FM ;
Maini, RN .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) :4126-4127
[3]   Anti-tumor necrosis factor therapy and Listeria monocytogenes infection:: report of two cases [J].
Glück, T ;
Linde, HJ ;
Schölmerich, J ;
Müller-Ladner, U ;
Fiehn, C ;
Bohland, P .
ARTHRITIS AND RHEUMATISM, 2002, 46 (08) :2255-2257
[4]   Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].
Keane, J ;
Gershon, S ;
Wise, RP ;
Mirabile-Levens, E ;
Kasznica, J ;
Schwieterman, WD ;
Siegel, JN ;
Braun, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104
[5]   Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-α therapy [J].
Kroesen, S ;
Widmer, AF ;
Tyndall, A ;
Hasler, P .
RHEUMATOLOGY, 2003, 42 (05) :617-621
[6]   Listeriosis [J].
Lorber, B .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :1-11
[7]  
Moreland LW, 2001, J RHEUMATOL, V28, P1238
[8]   Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α-neutralizing agents [J].
Slifman, NR ;
Gershon, SK ;
Lee, JH ;
Edwards, ET ;
Braun, MM .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :319-324
[9]   Effects of 2 different anti-tumor necrosis factor-α agents in a primate model of subcutaneous abscess formation [J].
Song, XYR ;
Fox, F ;
Gallo, MA ;
Rosenberg, A ;
Jordan, R ;
Shealy, D ;
Wagner, C .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (02) :204-213
[10]   A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate [J].
Weinblatt, ME ;
Kremer, JM ;
Bankhurst, AD ;
Bulpitt, KJ ;
Fleischmann, RM ;
Fox, RI ;
Jackson, CG ;
Lange, M ;
Burge, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :253-259